Biocon acquires Eywa Pharma’s New Jersey facility for $7.7 million
Biocon Ltd announced the acquisition of Eywa Pharma Inc’s solid oral drug manufacturing facility by its wholly owned subsidiary, Biocon Generics Inc, for $7.7 million. The biotech giant said in an exchange document that the facility in Cranbury, New Jersey, US has the potential to expand capacity by up to two billion tablets or capsules …
Biocon acquires Eywa Pharma’s New Jersey facility for $7.7 million Read More »